KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Cash & Equivalents: 2013-2025

Historic Cash & Equivalents for Ardelyx (ARDX) over the last 13 years, with Sep 2025 value amounting to $42.7 million.

  • Ardelyx's Cash & Equivalents fell 9.94% to $42.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.7 million, marking a year-over-year decrease of 9.94%. This contributed to the annual value of $64.9 million for FY2024, which is 202.43% up from last year.
  • Ardelyx's Cash & Equivalents amounted to $42.7 million in Q3 2025, which was down 52.56% from $90.0 million recorded in Q2 2025.
  • Ardelyx's 5-year Cash & Equivalents high stood at $96.1 million for Q4 2022, and its period low was $21.5 million during Q4 2023.
  • Moreover, its 3-year median value for Cash & Equivalents was $41.9 million (2024), whereas its average is $48.3 million.
  • In the last 5 years, Ardelyx's Cash & Equivalents plummeted by 77.67% in 2023 and then skyrocketed by 202.43% in 2024.
  • Quarterly analysis of 5 years shows Ardelyx's Cash & Equivalents stood at $72.4 million in 2021, then spiked by 32.74% to $96.1 million in 2022, then plummeted by 77.67% to $21.5 million in 2023, then skyrocketed by 202.43% to $64.9 million in 2024, then declined by 9.94% to $42.7 million in 2025.
  • Its last three reported values are $42.7 million in Q3 2025, $90.0 million for Q2 2025, and $30.8 million during Q1 2025.